| Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging M Fowler, J Virostko, Z Chen, G Poffenberger, A Radhika, M Brissova, ... Transplantation 79 (7), 768-776, 2005 | 133 | 2005 |
| Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer HC Manning, NB Merchant, AC Foutch, JM Virostko, SK Wyatt, C Shah, ... Clinical cancer research 14 (22), 7413-7422, 2008 | 126 | 2008 |
| Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004‐2015 J Virostko, A Capasso, TE Yankeelov, B Goodgame Cancer 125 (21), 3828-3835, 2019 | 119 | 2019 |
| Pancreas volume declines during the first year after diagnosis of type 1 diabetes and exhibits altered diffusion at disease onset J Virostko, J Williams, M Hilmes, C Bowman, JJ Wright, L Du, H Kang, ... Diabetes care 42 (2), 248-257, 2019 | 99 | 2019 |
| Bioluminescence imaging in mouse models quantifies β cell mass in the pancreas and after islet transplantation J Virostko, A Radhika, G Poffenberger, Z Chen, M Brissova, J Gilchrist, ... Molecular imaging and biology 12, 42-53, 2010 | 85 | 2010 |
| Fully convolutional neural networks improve abdominal organ segmentation MF Bobo, S Bao, Y Huo, Y Yao, J Virostko, AJ Plassard, I Lyu, A Assad, ... Medical Imaging 2018: Image Processing 10574, 750-757, 2018 | 84 | 2018 |
| Ectonucleoside triphosphate diphosphohydrolase-3 antibody targets adult human pancreatic β cells for in vitro and in vivo analysis DC Saunders, M Brissova, N Phillips, S Shrestha, JT Walker, ... Cell metabolism 29 (3), 745-754. e4, 2019 | 74 | 2019 |
| Integrated molecular imaging reveals tissue heterogeneity driving host-pathogen interactions JE Cassat, JL Moore, KJ Wilson, Z Stark, BM Prentice, R Van de Plas, ... Science translational medicine 10 (432), eaan6361, 2018 | 73 | 2018 |
| Factors influencing quantification of in vivo bioluminescence imaging: application to assessment of pancreatic islet transplants J Virostko, Z Chen, M Fowler, G Poffenberger, AC Powers, ED Jansen Molecular Imaging 3 (4), 15353500200404133, 2004 | 70 | 2004 |
| Optimal control theory for personalized therapeutic regimens in oncology: Background, history, challenges, and opportunities AM Jarrett, D Faghihi, DA Hormuth, EABF Lima, J Virostko, G Biros, D Patt, ... Journal of clinical medicine 9 (5), 1314, 2020 | 68 | 2020 |
| Assessment of MRI issues at 7 T for 28 implants and other objects AN Dula, J Virostko, FG Shellock American Journal of Roentgenology 202 (2), 401-405, 2014 | 63 | 2014 |
| Repeatability, reproducibility, and accuracy of quantitative mri of the breast in the community radiology setting AG Sorace, C Wu, SL Barnes, AM Jarrett, S Avery, D Patt, B Goodgame, ... Journal of Magnetic Resonance Imaging 48 (3), 695-707, 2018 | 57 | 2018 |
| Validation of luminescent source reconstruction using single-view spectrally resolved bioluminescence images J Virostko, AC Powers, ED Jansen Applied optics 46 (13), 2540-2547, 2007 | 55 | 2007 |
| Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology C Wu, G Lorenzo, DA Hormuth, EABF Lima, KP Slavkova, JC DiCarlo, ... Biophysics reviews 3 (2), 2022 | 54 | 2022 |
| Distinguishing benign and malignant breast tumors: preliminary comparison of kinetic modeling approaches using multi-institutional dynamic contrast-enhanced MRI data from the … AG Sorace, SC Partridge, X Li, J Virostko, SL Barnes, DS Hippe, W Huang, ... Journal of Medical Imaging 5 (1), 011019-011019, 2018 | 50 | 2018 |
| Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands J Virostko, J Henske, L Vinet, S Lamprianou, C Dai, A Radhika, ... Proceedings of the National Academy of Sciences 108 (51), 20719-20724, 2011 | 50 | 2011 |
| Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data AM Jarrett, DA Hormuth II, C Wu, AS Kazerouni, DA Ekrut, J Virostko, ... Neoplasia 22 (12), 820-830, 2020 | 48 | 2020 |
| SPARCL1 suppresses metastasis in prostate cancer Y Xiang, Q Qiu, M Jiang, R Jin, BD Lehmann, DW Strand, B Jovanovic, ... Molecular oncology 7 (6), 1019-1030, 2013 | 42 | 2013 |
| Effect of optical tissue clearing on spatial resolution<? xpp qa?> and sensitivity of bioluminescence imaging ED Jansen, PM Pickett, MA Mackanos, J Virostko Journal of Biomedical Optics 11 (4), 041119-041119-7, 2006 | 42 | 2006 |
| Use of the electronic medical record to assess pancreas size in type 1 diabetes J Virostko, M Hilmes, K Eitel, DJ Moore, AC Powers PloS one 11 (7), e0158825, 2016 | 39 | 2016 |
Thomas YankeelovDirector, Center for Computational Oncology, The University of Texas at AustinVerified email at utexas.edu
